HSBC Holdings
AMED

HSBC Holdings’s Amedisys AMED Stock Holding History

HSBC Holdings’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,000
Closed -$425K – 2910
2022
Q2 		$425K Buy
+4,000
New +$511K ﹤0.01% 2426

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HSBC Holdings's AMED Position: Q3 2025 in Review

HSBC Holdings sold out of Amedisys (AMED) in Q3 2025, closing a stake of 16,115 shares — an estimated $1.58M sold.

HSBC Holdings first reported a position in AMED in Q4 2016 and held it in 25 quarters. The position peaked at $10.5M in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • HSBC Holdings reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 16,115 Amedisys shares in Q3 2025, an estimated $1.58M.
  • HSBC Holdings first reported a position in Amedisys in Q4 2016 and held it in 25 quarters.
  • HSBC Holdings's Amedisys position peaked at $10.5M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.